• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·JSTL.BO
Share

Jeevan Scientific Technology Limited Stocks

₹ 88.62Last Updated 19.10.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

₹ 18.72M

₹ 88.62
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Jeevan Scientific Technology Ltd. functions as an outsourcing enterprise, offering global management consulting and technological solutions. The company's activities are divided into two principal divisions: Clinical Research Services and Information Technology Services. It was established on February 2, 1999, and its main corporate offices are located in Hyderabad, India.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.10.2026 15:25

Morning in New York: Earnings Reports Will Test the Sustainability of the AI Stock Rally

20.10.2026 15:24

Reuters identified a possible cause of the Revolut outage

20.10.2026 15:08

Ryanair's CEO predicted the "largest in history" increase in airfare prices in Europe

20.10.2026 14:26

From PDF files to drone defense: How Finland's newest billionaire built his business

20.10.2026 13:42

Revolut Experiences an Outage: Customers Report Issues with Payments and the App

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026